Ultrasound-Guided Microendoscopic Versus Fluoroscopic-Guided Lumbar Transforaminal Epidural Steroid Injections

NCT ID: NCT05729022

Last Updated: 2024-06-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

124 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-12-01

Study Completion Date

2025-12-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to compare the Microendoscopic combined with ultrasound technique to the standard routinely used X-ray guided transforaminal steroid injection technique.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

After being informed about the study and potential risks, all patients giving written informed consent will undergo screening to determine eligibility. Patients who meet the eligibility criteria will be randomized in a double-blind manner to two groups. Patients assigned to Group A will undergo a fluoroscopy guided procedure while patients in Group B will undergo a microendoscopic combined with ultrasound technique.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Radiculopathy Lumbar Disc Disease Lumbar

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Fluoroscopy

A local anesthetic (2% lidocaine), a 22G, 90mm needle (Quincke spinal needle) is inserted into the skin. Once the needle tip is in its target position, 0.5-5 cc of contrast (Omnipauqe) is injected. If the contrast spread along the spinal nerve into the epidural space, a mixture of 3 cc of 0.125% Marcaine and 40 mg of Depo-Medrol is injected or Diprofos (1/2 ampoule (2 ml) per level).

Group Type PLACEBO_COMPARATOR

Fluoroscopy

Intervention Type RADIATION

Fluoroscopy-guided lumbar transforaminal epidural steroid injection.

Ultrasound Microendoscopic

A US device with a curvilinear probe and with a microendoscope (EvoTouch+7 Star Scope), inserted into an 18G needle is used. This group will also receive one AP view fluoroscopy (as control) to check for the diffusion of the contrast material in the epidural space.

Group Type EXPERIMENTAL

Ultrasound microendoscopic technique

Intervention Type DEVICE

Ultrasound-guided microendoscopic lumbar transforaminal epidural steroid injection

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Ultrasound microendoscopic technique

Ultrasound-guided microendoscopic lumbar transforaminal epidural steroid injection

Intervention Type DEVICE

Fluoroscopy

Fluoroscopy-guided lumbar transforaminal epidural steroid injection.

Intervention Type RADIATION

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age between 18 and 64 years old of either sex
* Disease status of American Society of Anesthesiologists grades I to II
* Patients presenting with single-level disc disease and radiculopathy (L2-L3; L3-L4; L4-L5) for steroid injection
* Confirmation of herniated disk by CT or MRI
* Able to give informed consent

Exclusion Criteria

* Age under 18 or over 64 years old
* Pregnant women
* Disease status of American Society of Anesthesiologists grades III to IV
* Unable to provide an informed consent
* Radiculopathies at multiple spinal levels
* Non-lumbar herniated discs
* Clinically obvious or known spinal deformity or stenosis
* Previous spine surgery
* Local or systemic infection
* Allergy to steroids, anesthetics, or contrast material
* Uncorrectable coagulopathy and patients on anticoagulation therapy
* Patients who refuse the procedure
* Spine tuberculosis or tumors
* Prior injections within 3 months
Minimum Eligible Age

18 Years

Maximum Eligible Age

64 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Quantel Medical

INDUSTRY

Sponsor Role collaborator

American University of Beirut Medical Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Marwan Rizk

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Marwan Rizk, MD

Role: PRINCIPAL_INVESTIGATOR

American University of Beirut Medical Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

American University of Beirut Medical Center

Beirut, , Lebanon

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Lebanon

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Marwan Rizk, MD

Role: CONTACT

+9611350000 ext. 6380

Thouraya HajAli, MSc

Role: CONTACT

+9611350000 ext. 5738

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Marwan Rizk, MD

Role: primary

References

Explore related publications, articles, or registry entries linked to this study.

Manchikanti L. Transforaminal lumbar epidural steroid injections. Pain Physician. 2000 Oct;3(4):374-98.

Reference Type BACKGROUND
PMID: 16906179 (View on PubMed)

Wu A, March L, Zheng X, Huang J, Wang X, Zhao J, Blyth FM, Smith E, Buchbinder R, Hoy D. Global low back pain prevalence and years lived with disability from 1990 to 2017: estimates from the Global Burden of Disease Study 2017. Ann Transl Med. 2020 Mar;8(6):299. doi: 10.21037/atm.2020.02.175.

Reference Type BACKGROUND
PMID: 32355743 (View on PubMed)

Mehta N, Salaria M, Salaria AQ. Comparison of fluoroscopic Guided Transforaminal Epidural Injections of Steroid and Local Anaesthetic with Conservative Management in Patients with Chronic Lumbar Radiculopathies. Anesth Essays Res. 2017 Jan-Mar;11(1):17-22. doi: 10.4103/0259-1162.186868.

Reference Type BACKGROUND
PMID: 28298750 (View on PubMed)

Hashemi M, Dadkhah P, Taheri M, Haji Seyed Abootorabi SM, Naderi-Nabi B. Ultrasound-Guided Lumbar Transforaminal Epidural Injections; A Single Center Fluoroscopic Validation Study. Bull Emerg Trauma. 2019 Jul;7(3):251-255. doi: 10.29252/beat-070307.

Reference Type BACKGROUND
PMID: 31392224 (View on PubMed)

Jee H, Lee JH, Kim J, Park KD, Lee WY, Park Y. Ultrasound-guided selective nerve root block versus fluoroscopy-guided transforaminal block for the treatment of radicular pain in the lower cervical spine: a randomized, blinded, controlled study. Skeletal Radiol. 2013 Jan;42(1):69-78. doi: 10.1007/s00256-012-1434-1. Epub 2012 May 20.

Reference Type BACKGROUND
PMID: 22609989 (View on PubMed)

Engel A, King W, MacVicar J; Standards Division of the International Spine Intervention Society. The effectiveness and risks of fluoroscopically guided cervical transforaminal injections of steroids: a systematic review with comprehensive analysis of the published data. Pain Med. 2014 Mar;15(3):386-402. doi: 10.1111/pme.12304. Epub 2013 Dec 5.

Reference Type BACKGROUND
PMID: 24308846 (View on PubMed)

Yang G, Liu J, Ma L, Cai Z, Meng C, Qi S, Zhou H. Ultrasound-guided Versus Fluoroscopy-controlled Lumbar Transforaminal Epidural Injections: A Prospective Randomized Clinical Trial. Clin J Pain. 2016 Feb;32(2):103-8. doi: 10.1097/AJP.0000000000000237.

Reference Type BACKGROUND
PMID: 25803759 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

BIO-2022-0218

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.